Literature DB >> 24198287

Incidence and risk factors of chronic kidney disease in korean patients with t1a renal cell carcinoma before and after radical or partial nephrectomy.

Sung Han Kim1, Sang Eun Lee, Sung Kyu Hong, Chang Wook Jeong, Yong Hyun Park, Yong-June Kim, Seok Ho Kang, Sung-Hoo Hong, Won Suk Choi, Seok-Soo Byun.   

Abstract

OBJECTIVE: The aim of the study was to investigate the incidence of chronic kidney disease in patients with T1a renal cell carcinoma both before and after partial or radical nephrectomy, and to assess risk factors for chronic kidney disease.
METHODS: From January 2001 to December 2011, 1928 patients with a single renal mass ≤4 cm undergoing partial nephrectomy or radical nephrectomy with the existence of a normal contralateral kidney were retrospectively reviewed for the evaluation of preoperative chronic kidney disease, and reviewed only 1676 patients for the postoperative chronic kidney disease. The estimated glomerular filtration rates were used to define chronic kidney disease <60 ml/min/1.73 m(2) by the Modification of Diet in Renal Disease equation. Demographics and clinicopathological parameters were evaluated to determine the risk factors with the development of chronic kidney disease both before and after surgery.
RESULTS: Chronic kidney disease was found preoperatively in 10.0% (n = 192) of patients; 16.1% (n = 269) of patients developed chronic kidney disease postoperatively, including 102 (6.1%) chronic kidney disease patients >65 years of age. Between the non-chronic kidney disease and chronic kidney disease patients, male gender (odds ratio 3.55 vs. 3.78, respectively) and diagnostic age (odds ratio 1.04 vs. 1.05) were significantly distinctive common risk factors for chronic kidney disease both before and after surgery (P < 0.002). In addition, hypertension (odds ratio 0.46), serum albumin (odds ratio 0.23) and calcium (odds ratio 2.06) were significant as preoperative risk factors (P < 0.015), and preoperative serum creatinine (odds ratio 1.90) and surgical type (partial nephrectomy or radical nephrectomy; odds ratio 11.89) were significant as postoperative risk factors (P < 0.030).
CONCLUSIONS: Old, male hypertensive patients with a small renal mass would be better candidates for partial nephrectomy to prevent postoperative chronic kidney disease.

Entities:  

Keywords:  carcinoma; chronic; incidence; nephrectomy; renal cell; renal insufficiency; risk factors

Mesh:

Substances:

Year:  2013        PMID: 24198287     DOI: 10.1093/jjco/hyt149

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  14 in total

1.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

2.  End-Stage Kidney Disease following Surgical Management of Kidney Cancer.

Authors:  Robert J Ellis; Daniel P Edey; Sharon J Del Vecchio; Megan McStea; Scott B Campbell; Carmel M Hawley; David W Johnson; Christudas Morais; Susan J Jordan; Ross S Francis; Simon T Wood; Glenda C Gobe
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-28       Impact factor: 8.237

Review 3.  Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.

Authors:  Frank Kunath; Stefanie Schmidt; Laura-Maria Krabbe; Arkadiusz Miernik; Philipp Dahm; Anne Cleves; Mario Walther; Nils Kroeger
Journal:  Cochrane Database Syst Rev       Date:  2017-05-09

Review 4.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

Review 5.  Renal cell carcinoma: new insights and challenges for a clinician scientist.

Authors:  Roman Shingarev; Edgar A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-05

6.  Advantages of organ-sparing treatment approaches in metastatic kidney cancer.

Authors:  Iurii Vitruk; Oleg Voylenko; Oleksandr Stakhovsky; Oleksii Kononenko; Maksym Pikul; Sofiya Semko; Bohdan Hrechko; Denis Koshel; Eduard Stakhovsky
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-23       Impact factor: 4.322

Review 7.  Risk of chronic kidney disease after nephrectomy for renal cell carcinoma.

Authors:  Seung-Kwon Choi; Cheryn Song
Journal:  Korean J Urol       Date:  2014-10-10

8.  Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Sun-Seog Kweon; Soo Wan Kim
Journal:  BMC Nephrol       Date:  2014-11-19       Impact factor: 2.388

9.  Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.

Authors:  Guenther Schneider; Thorsten Probst; Miles A Kirchin; Jonas Stroeder; Peter Fries; Arno Buecker
Journal:  Radiol Med       Date:  2015-06-19       Impact factor: 3.469

10.  A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up.

Authors:  Sung Han Kim; Kyung Min Kang; Ami Yu; Jung Hoon Lee; Byung Ho Nam; Eun Sik Lee
Journal:  Cancer Res Treat       Date:  2015-04-15       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.